Keyphrases
Progressive multifocal Leukoencephalopathy
100%
Patient Survival
100%
Patient Management
100%
MR Finding
100%
Mass Effect
83%
Lesion Size
33%
T1-weighted
33%
Lesion Location
33%
Multivariate Analysis
16%
Long-term Survival
16%
Contrast Enhancement
16%
Univariate Analysis
16%
HIV Patients
16%
Non-contrast
16%
Statistical Analysis
16%
Atrophy
16%
Cortical Atrophy
16%
Prospective Clinical Trial
16%
T2-weighted Imaging (T2WI)
16%
Risk of Death
16%
Limited Samples
16%
AIDS Patients
16%
Multicenter Clinical Trial
16%
Patient Cohort
16%
Weighted Contrast
16%
Tissue Diagnosis
16%
Cytosine Arabinoside
16%
Ventricular Dilatation
16%
Contrast-enhanced Images
16%
Prognostic Sign
16%
Medicine and Dentistry
Patient Care
100%
Progressive Multifocal Leukoencephalopathy
100%
Clinical Trial
33%
Human Immunodeficiency Virus
16%
Cytarabine
16%
Univariate Analysis
16%
Multivariate Analysis
16%
Retrospective Study
16%
Biopsy Technique
16%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Sample Size
100%
Dilatation
100%
Neuroscience
Progressive Multifocal Leukoencephalopathy
100%
Human Immunodeficiency Virus
16%
Cytarabine
16%